Engimata provides vaccine components and design, vaccine development, vaccine adjuvant, covid-19 vaccine, and lyophilization. They also offer ultra-cold supply chain, peptides, recombinant protein antigens and protein sub-units, and patented platform adjuvant technology.
Partial Data by Infogroup (c) 2024. All rights reserved.